Literature DB >> 21274424

Prediction based classification for longitudinal biomarkers.

A S Foulkes1, L Azzoni, X Li, M A Johnson, C Smith, K Mounzer, L J Montaner.   

Abstract

Assessment of circulating CD4 count change over time in HIV-infected subjects on antiretroviral therapy (ART) is a central component of disease monitoring. The increasing number of HIV-infected subjects starting therapy and the limited capacity to support CD4 count testing within resource-limited settings have fueled interest in identifying correlates of CD4 count change such as total lymphocyte count, among others. The application of modeling techniques will be essential to this endeavor due to the typically non-linear CD4 trajectory over time and the multiple input variables necessary for capturing CD4 variability. We propose a prediction based classification approach that involves first stage modeling and subsequent classification based on clinically meaningful thresholds. This approach draws on existing analytical methods described in the receiver operating characteristic curve literature while presenting an extension for handling a continuous outcome. Application of this method to an independent test sample results in greater than 98% positive predictive value for CD4 count change. The prediction algorithm is derived based on a cohort of n = 270 HIV-1 infected individuals from the Royal Free Hospital, London who were followed for up to three years from initiation of ART. A test sample comprised of n = 72 individuals from Philadelphia and followed for a similar length of time is used for validation. Results suggest that this approach may be a useful tool for prioritizing limited laboratory resources for CD4 testing after subjects start antiretroviral therapy.

Entities:  

Year:  2010        PMID: 21274424      PMCID: PMC3026390          DOI: 10.1214/10-AOAS326

Source DB:  PubMed          Journal:  Ann Appl Stat        ISSN: 1932-6157            Impact factor:   2.083


  25 in total

1.  Characterizing the relationship between HIV-1 genotype and phenotype: prediction-based classification.

Authors:  A S Foulkes; Gruttola V De
Journal:  Biometrics       Date:  2002-03       Impact factor: 2.571

2.  The potential for CD4 cell increases in HIV-positive individuals who control viraemia with highly active antiretroviral therapy.

Authors:  Colette J Smith; Caroline A Sabin; Fiona C Lampe; Sabine Kinloch-de-Loes; Helen Gumley; Anne Carroll; Beth Prinz; Mike Youle; Margaret A Johnson; Andrew N Phillips
Journal:  AIDS       Date:  2003-05-02       Impact factor: 4.177

3.  Characterizing classes of antiretroviral drugs by genotype.

Authors:  A S Foulkes; V DeGruttola
Journal:  Stat Med       Date:  2003-08-30       Impact factor: 2.373

4.  Changes in total lymphocyte count as a surrogate for changes in CD4 count following initiation of HAART: implications for monitoring in resource-limited settings.

Authors:  Anish P Mahajan; Joseph W Hogan; Brad Snyder; N Kumarasamy; Kalindi Mehta; Suniti Solomon; Charles C J Carpenter; Kenneth H Mayer; Timothy P Flanigan
Journal:  J Acquir Immune Defic Syndr       Date:  2004-05-01       Impact factor: 3.731

5.  Can routine clinical markers be used longitudinally to monitor antiretroviral therapy success in resource-limited settings?

Authors:  Shashwatee Bagchi; Mirjam C Kempf; Andrew O Westfall; Anastasiya Maherya; James Willig; Michael S Saag
Journal:  Clin Infect Dis       Date:  2006-11-28       Impact factor: 9.079

6.  Random effects modeling approaches for estimating ROC curves from repeated ordinal tests without a gold standard.

Authors:  Paul S Albert
Journal:  Biometrics       Date:  2007-06       Impact factor: 2.571

7.  Random-effects models for longitudinal data.

Authors:  N M Laird; J H Ware
Journal:  Biometrics       Date:  1982-12       Impact factor: 2.571

8.  Total lymphocyte count and hemoglobin combined in an algorithm to initiate the use of highly active antiretroviral therapy in resource-limited settings.

Authors:  Lisa A Spacek; Michael Griswold; Thomas C Quinn; Richard D Moore
Journal:  AIDS       Date:  2003-06-13       Impact factor: 4.177

9.  Total lymphocyte count of 1200 is not a sensitive predictor of CD4 lymphocyte count among patients with HIV disease in Kampala, Uganda.

Authors:  Moses R Kamya; Fred C Semitala; Thomas C Quinn; Allan Ronald; Denise Njama-Meya; Harriet Mayanja-Kizza; Elly T Katabira; Lisa A Spacek
Journal:  Afr Health Sci       Date:  2004-08       Impact factor: 0.927

10.  ROC curve regression analysis: the use of ordinal regression models for diagnostic test assessment.

Authors:  A N Tosteson; M C Weinstein; J Wittenberg; C B Begg
Journal:  Environ Health Perspect       Date:  1994-11       Impact factor: 9.031

View more
  8 in total

1.  The ROC curve for regularly measured longitudinal biomarkers.

Authors:  Haben Michael; Lu Tian; Musie Ghebremichael
Journal:  Biostatistics       Date:  2019-07-01       Impact factor: 5.899

2.  Optimal Allocation of Gold Standard Testing under Constrained Availability: Application to Assessment of HIV Treatment Failure.

Authors:  Tao Liu; Joseph W Hogan; Lisa Wang; Shangxuan Zhang; Rami Kantor
Journal:  J Am Stat Assoc       Date:  2013-01-01       Impact factor: 5.033

3.  A linear mixed model for predicting a binary event from longitudinal data under random effects misspecification.

Authors:  Paul S Albert
Journal:  Stat Med       Date:  2011-11-14       Impact factor: 2.373

4.  Bayesian semiparametric joint modeling of longitudinal explanatory variables of mixed types and a binary outcome.

Authors:  Woobeen Lim; Michael L Pennell; Michelle J Naughton; Electra D Paskett
Journal:  Stat Med       Date:  2021-10-17       Impact factor: 2.497

5.  Prioritizing CD4 count monitoring in response to ART in resource-constrained settings: a retrospective application of prediction-based classification.

Authors:  Livio Azzoni; Andrea S Foulkes; Yan Liu; Xiaohong Li; Margaret Johnson; Collette Smith; Adeeba Bte Kamarulzaman; Julio Montaner; Karam Mounzer; Michael Saag; Pedro Cahn; Carina Cesar; Alejandro Krolewiecki; Ian Sanne; Luis J Montaner
Journal:  PLoS Med       Date:  2012-04-17       Impact factor: 11.069

6.  Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer.

Authors:  Yunee Kim; Jouhyun Jeon; Salvador Mejia; Cindy Q Yao; Vladimir Ignatchenko; Julius O Nyalwidhe; Anthony O Gramolini; Raymond S Lance; Dean A Troyer; Richard R Drake; Paul C Boutros; O John Semmes; Thomas Kislinger
Journal:  Nat Commun       Date:  2016-06-28       Impact factor: 14.919

7.  Use of paediatric early warning scores in intermediate care units.

Authors:  Marie Emilie Lampin; Alain Duhamel; Hélène Behal; Morgan Recher; Francis Leclerc; Stéphane Leteurtre
Journal:  Arch Dis Child       Date:  2019-08-10       Impact factor: 3.791

8.  Dynamic predictive probabilities to monitor rapid cystic fibrosis disease progression.

Authors:  Rhonda D Szczesniak; Weiji Su; Cole Brokamp; Ruth H Keogh; John P Pestian; Michael Seid; Peter J Diggle; John P Clancy
Journal:  Stat Med       Date:  2019-12-09       Impact factor: 2.373

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.